Market Performance - The Shanghai Composite Index rose by 0.43% to 3399.77 points, marking a five-day consecutive increase [1] - The Shenzhen Component Index increased by 0.65% to 10250.14 points, while the ChiNext Index gained 1.07% to 2061.29 points [1] - Total trading volume in the two markets reached 1.29 trillion yuan, exceeding 1 trillion yuan for eight consecutive days [1] Industry Highlights - The entertainment products sector saw a significant increase of 4.93%, followed by commercial vehicles and chemical pharmaceuticals, which rose by 3.73% and 3.70% respectively [1] - A total of 968 non-currency ETFs rose, with an increase ratio of 84% [1] ETF Performance - The CSI Hong Kong Innovation Drug Index increased by 5.39%, with various related ETFs also showing strong performance, such as the Hong Kong Innovation Drug ETF and the Hong Kong Innovation Drug 50 ETF, which rose by 4.65% and 4.56% respectively [1] - The latest share size of the Hong Kong Innovation Drug ETF reached 9.157 billion shares, closely tracking the CSI Hong Kong Innovation Drug RMB Index [3] - The latest P/E ratio (PE-TTM) for the CSI Hong Kong Innovation Drug Index is 29.28, which is lower than 16.54% of the time over the past three years [4][6] Sector Valuation - The Hang Seng Medical ETF has a latest share size of 1.664 billion shares, tracking the Hang Seng Hong Kong Stock Connect Medical Care Index, which reflects the performance of Hong Kong-listed companies in pharmaceuticals and biotechnology [4] - The latest P/E ratio for the Hang Seng Hong Kong Stock Connect Medical Care Index is 32.30, below 32.20% of the time over the past three years [5] Market Trends - A total of 123 non-currency ETFs declined, with a decrease ratio of 11% [7] - The gold industry theme index saw the largest decline, dropping by 1.11% [7]
ETF英雄汇：港股创新药ETF(513120.SH)领涨、多只QDII溢价明显-20250609